Friday, July 31, 2026

Ovens That Think: LG’s SKS Turns Up the Heat on High-End Kitchens

LG Electronics' SKS impresses at the Food & Wine Classic with innovative kitchen appliances, featuring gas, induction, and sous-vide cooking.

Seattle Seahawks Begin Sale Process After Super Bowl Victory: What’s Next for the NFL Team?

The Seattle Seahawks, fresh off their Super Bowl LVIII win, are set to change ownership, fulfilling Paul Allen's philanthropic vision.

North Korea Unveils New Military Drones: What Does This Mean for Regional Security in 2025?

North Korea showcased new air force capabilities, including drones and missiles, during the 80th anniversary ceremony led by Kim Jong Un.

Tag: Mounjaro

Novo Nordisk vs Eli Lilly: Is Weight Loss Advertising Misleading?

Novo Nordisk sues Eli Lilly for misleading ads on obesity drugs, claiming false comparisons and seeking corrective action in court.

Teen Prescriptions for GLP-1 Obesity Drugs Surge in Korea, Raising Misuse Concerns

Surge in GLP-1 obesity treatment prescriptions among teens raises concerns over misuse and potential health risks.

Mounjaro prescriptions surge 12-fold in 8 months, surpassing 200,000 monthly for the first time

Mounjaro prescriptions surged over tenfold in eight months, raising concerns about access for patients with obesity amid rising cosmetic demand.

Why Are Weight-Loss Drugs So Much Pricier in South Korea?

South Korea faces high obesity treatment costs compared to China and Japan, with no insurance coverage, despite potential patent expirations.

Ozempic Maker Swaps CEO, Bets $2.2B on New Obesity Drug Fight

Novo Nordisk's leadership change aims to reclaim its obesity treatment market share amid competition from Eli Lilly's Mounjaro.

New Study: Mounjaro Helps Users Drop Over 50 Pounds

Eli Lilly's Mounjaro leads U.S. obesity drug market, outperforming semaglutide in weight loss efficacy and safety.

Top News

- Our Sponsors Ad -

Follow us